Christopher L. Chavez, Ph.D. - Publications

Affiliations: 
2005 University of California, Santa Cruz, Santa Cruz, CA, United States 
Area:
Molecular Biology, Genetics

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Neitz M, Neitz J, Crain AC, Chavez CL, Alcamo E, Vijay S, Kniffin T, Moradi E, Ni M, Woodburn KW, Chalberg TW. 202. pMNTC Is a Cone-Specific Regulatory Cassette Designed To Treat Cone-Associated Disorders Molecular Therapy. 23: S80. DOI: 10.1016/S1525-0016(16)33807-2  0.624
2014 Zhao C, Farruggio AP, Bjornson CR, Chavez CL, Geisinger JM, Neal TL, Karow M, Calos MP. Recombinase-mediated reprogramming and dystrophin gene addition in mdx mouse induced pluripotent stem cells. Plos One. 9: e96279. PMID 24781921 DOI: 10.1371/Journal.Pone.0096279  0.61
2012 Farruggio AP, Chavez CL, Mikell CL, Calos MP. Efficient reversal of phiC31 integrase recombination in mammalian cells. Biotechnology Journal. 7: 1332-6. PMID 22933343 DOI: 10.1002/Biot.201200283  0.6
2012 Chavez CL, Keravala A, Chu JN, Farruggio AP, Cuéllar VE, Voorberg J, Calos MP. Long-term expression of human coagulation factor VIII in a tolerant mouse model using the φC31 integrase system. Human Gene Therapy. 23: 390-8. PMID 22077817 DOI: 10.1089/Hum.2011.110  0.637
2011 Karow M, Chavez CL, Farruggio AP, Geisinger JM, Keravala A, Jung WE, Lan F, Wu JC, Chen-Tsai Y, Calos MP. Site-specific recombinase strategy to create induced pluripotent stem cells efficiently with plasmid DNA. Stem Cells (Dayton, Ohio). 29: 1696-704. PMID 21898697 DOI: 10.1002/Stem.730  0.585
2011 Chavez CL, Calos MP. Therapeutic applications of the ΦC31 integrase system. Current Gene Therapy. 11: 375-81. PMID 21888619 DOI: 10.2174/156652311797415818  0.635
2011 Keravala A, Chavez CL, Hu G, Woodard LE, Monahan PE, Calos MP. Long-term phenotypic correction in factor IX knockout mice by using ΦC31 integrase-mediated gene therapy. Gene Therapy. 18: 842-8. PMID 21412285 DOI: 10.1038/Gt.2011.31  0.654
2010 Chavez CL, Keravala A, Woodard LE, Hillman RT, Stowe TR, Chu JN, Calos MP. Kinetics and longevity of ΦC31 integrase in mouse liver and cultured cells. Human Gene Therapy. 21: 1287-97. PMID 20497035 DOI: 10.1089/Hum.2010.049  0.632
2006 Chavez C, Bowman EJ, Reidling JC, Haw KH, Bowman BJ. Analysis of strains with mutations in six genes encoding subunits of the V-ATPase: Eukaryotes differ in the composition of the V0 sector of the enzyme Journal of Biological Chemistry. 281: 27052-27062. PMID 16857684 DOI: 10.1074/Jbc.M603883200  0.588
Show low-probability matches.